Logo image of ICOS.MI

INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:ICOS - IT0005455875 - Common Stock

10.92 EUR
-0.08 (-0.73%)
Last: 12/11/2025, 5:35:30 PM
Fundamental Rating

4

Overall ICOS gets a fundamental rating of 4 out of 10. We evaluated ICOS against 16 industry peers in the Personal Care Products industry. The financial health of ICOS is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ICOS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ICOS had positive earnings in the past year.
ICOS had a positive operating cash flow in the past year.
Each year in the past 5 years ICOS has been profitable.
ICOS had a positive operating cash flow in each of the past 5 years.
ICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

With a Return On Assets value of 4.71%, ICOS is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 10.16%, ICOS is doing worse than 62.50% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 9.59%, ICOS is in line with its industry, outperforming 56.25% of the companies in the same industry.
ICOS had an Average Return On Invested Capital over the past 3 years of 9.32%. This is below the industry average of 11.47%.
The 3 year average ROIC (9.32%) for ICOS is below the current ROIC(9.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROIC 9.59%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ICOS.MI Yearly ROA, ROE, ROICICOS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ICOS has a Profit Margin of 4.34%. This is in the lower half of the industry: ICOS underperforms 62.50% of its industry peers.
In the last couple of years the Profit Margin of ICOS has declined.
With a Operating Margin value of 9.31%, ICOS perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
In the last couple of years the Operating Margin of ICOS has declined.
ICOS has a Gross Margin of 19.84%. This is amonst the worse of the industry: ICOS underperforms 93.75% of its industry peers.
In the last couple of years the Gross Margin of ICOS has declined.
Industry RankSector Rank
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
ICOS.MI Yearly Profit, Operating, Gross MarginsICOS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ICOS is creating some value.
Compared to 1 year ago, ICOS has about the same amount of shares outstanding.
The number of shares outstanding for ICOS has been increased compared to 5 years ago.
The debt/assets ratio for ICOS is higher compared to a year ago.
ICOS.MI Yearly Shares OutstandingICOS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICOS.MI Yearly Total Debt VS Total AssetsICOS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ICOS has an Altman-Z score of 3.33. This indicates that ICOS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.33, ICOS is in line with its industry, outperforming 50.00% of the companies in the same industry.
ICOS has a debt to FCF ratio of 16.66. This is a negative value and a sign of low solvency as ICOS would need 16.66 years to pay back of all of its debts.
With a Debt to FCF ratio value of 16.66, ICOS is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.52 indicates that ICOS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, ICOS is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Altman-Z 3.33
ROIC/WACC1.45
WACC6.6%
ICOS.MI Yearly LT Debt VS Equity VS FCFICOS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

ICOS has a Current Ratio of 1.67. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
ICOS has a Current ratio of 1.67. This is amongst the best in the industry. ICOS outperforms 81.25% of its industry peers.
A Quick Ratio of 1.03 indicates that ICOS should not have too much problems paying its short term obligations.
ICOS has a Quick ratio of 1.03. This is in the better half of the industry: ICOS outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.03
ICOS.MI Yearly Current Assets VS Current LiabilitesICOS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

ICOS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.80%.
ICOS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.57% yearly.
ICOS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.02%.
Measured over the past years, ICOS shows a quite strong growth in Revenue. The Revenue has been growing by 8.36% on average per year.
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%

3.2 Future

Based on estimates for the next years, ICOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.03% on average per year.
ICOS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.81% yearly.
EPS Next Y4.9%
EPS Next 2Y11.54%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue Next Year0.74%
Revenue Next 2Y3.1%
Revenue Next 3Y3.95%
Revenue Next 5Y1.81%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICOS.MI Yearly Revenue VS EstimatesICOS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ICOS.MI Yearly EPS VS EstimatesICOS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.29, the valuation of ICOS can be described as rather expensive.
ICOS's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of ICOS to the average of the S&P500 Index (26.59), we can say ICOS is valued inline with the index average.
With a Price/Forward Earnings ratio of 13.86, ICOS is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICOS indicates a somewhat cheap valuation: ICOS is cheaper than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.80. ICOS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 22.29
Fwd PE 13.86
ICOS.MI Price Earnings VS Forward Price EarningsICOS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

68.75% of the companies in the same industry are more expensive than ICOS, based on the Enterprise Value to EBITDA ratio.
87.50% of the companies in the same industry are cheaper than ICOS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 67.18
EV/EBITDA 7.57
ICOS.MI Per share dataICOS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ICOS's earnings are expected to grow with 12.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.55
PEG (5Y)14.18
EPS Next 2Y11.54%
EPS Next 3Y12.03%

3

5. Dividend

5.1 Amount

ICOS has a Yearly Dividend Yield of 1.72%. Purely for dividend investing, there may be better candidates out there.
ICOS's Dividend Yield is comparable with the industry average which is at 2.78.
Compared to the average S&P500 Dividend Yield of 2.31, ICOS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

38.09% of the earnings are spent on dividend by ICOS. This is a low number and sustainable payout ratio.
DP38.09%
EPS Next 2Y11.54%
EPS Next 3Y12.03%
ICOS.MI Yearly Income VS Free CF VS DividendICOS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICOS.MI Dividend Payout.ICOS.MI Dividend Payout, showing the Payout Ratio.ICOS.MI Dividend Payout.PayoutRetained Earnings

INTERCOS SPA

BIT:ICOS (12/11/2025, 5:35:30 PM)

10.92

-0.08 (-0.73%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-02 2026-03-02/amc
Inst Owners36.58%
Inst Owner ChangeN/A
Ins Owners32.17%
Ins Owner ChangeN/A
Market Cap1.05B
Revenue(TTM)1.09B
Net Income(TTM)47.30M
Analysts85
Price Target16.87 (54.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP38.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.96%
PT rev (3m)-2.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.27%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.09%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 22.29
Fwd PE 13.86
P/S 0.97
P/FCF 67.18
P/OCF 11.76
P/B 2.26
P/tB 3.95
EV/EBITDA 7.57
EPS(TTM)0.49
EY4.49%
EPS(NY)0.79
Fwd EY7.21%
FCF(TTM)0.16
FCFY1.49%
OCF(TTM)0.93
OCFY8.5%
SpS11.31
BVpS4.83
TBVpS2.76
PEG (NY)4.55
PEG (5Y)14.18
Graham Number7.3
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROCE 14.65%
ROIC 9.59%
ROICexc 11.59%
ROICexgc 17.27%
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
FCFM 1.44%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ROICexc(3y)12.89%
ROICexc(5y)11.65%
ROICexgc(3y)22.3%
ROICexgc(5y)20.57%
ROCE(3y)14.06%
ROCE(5y)12.06%
ROICexgc growth 3Y0.58%
ROICexgc growth 5Y-13.66%
ROICexc growth 3Y4.35%
ROICexc growth 5Y-9.88%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
F-Score7
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Debt/EBITDA 1.6
Cap/Depr 144.42%
Cap/Sales 6.77%
Interest Coverage 11.2
Cash Conversion 58.65%
Profit Quality 33.11%
Current Ratio 1.67
Quick Ratio 1.03
Altman-Z 3.33
F-Score7
WACC6.6%
ROIC/WACC1.45
Cap/Depr(3y)119.92%
Cap/Depr(5y)113.2%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.95%
Profit Quality(3y)77.95%
Profit Quality(5y)89.83%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
EPS Next Y4.9%
EPS Next 2Y11.54%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%
Revenue Next Year0.74%
Revenue Next 2Y3.1%
Revenue Next 3Y3.95%
Revenue Next 5Y1.81%
EBIT growth 1Y16.33%
EBIT growth 3Y15.34%
EBIT growth 5Y2.71%
EBIT Next Year72.73%
EBIT Next 3Y26.54%
EBIT Next 5YN/A
FCF growth 1Y-69.82%
FCF growth 3Y14.23%
FCF growth 5Y-3.11%
OCF growth 1Y-14.11%
OCF growth 3Y17%
OCF growth 5Y3.39%

INTERCOS SPA / ICOS.MI FAQ

What is the ChartMill fundamental rating of INTERCOS SPA (ICOS.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ICOS.MI.


What is the valuation status of INTERCOS SPA (ICOS.MI) stock?

ChartMill assigns a valuation rating of 3 / 10 to INTERCOS SPA (ICOS.MI). This can be considered as Overvalued.


How profitable is INTERCOS SPA (ICOS.MI) stock?

INTERCOS SPA (ICOS.MI) has a profitability rating of 3 / 10.


Can you provide the financial health for ICOS stock?

The financial health rating of INTERCOS SPA (ICOS.MI) is 4 / 10.


What is the expected EPS growth for INTERCOS SPA (ICOS.MI) stock?

The Earnings per Share (EPS) of INTERCOS SPA (ICOS.MI) is expected to grow by 4.9% in the next year.